STD Testing Market To Surpass USD 141 Million By 2030 At A CAGR Of 4.7%

STD Testing Market To Surpass USD 141 Million By 2030 At A CAGR Of 4.7%

Acumen Research and Consulting has announced the addition of the “STD Testing Market” report to their offering.

The STD Testing Market Industry Report 2030 is an in depth study analyzing the current state of the STD Testing Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on STD Testing Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on STD Testing Market also discusses the opportunity areas for investors.

Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/3052

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

STD Testing MarketMarket Players as below:

Some of the top STD testing companies offered in the professional report include Abbott Laboratories, Affymetrix, Alere Inc., bioMérieux, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid Inc., Danaher Corporation, DiaSorin, Hologic Inc., Orasure, and Roche Holdings AG.

Market Segmentation:

Market by Disease Type

  • Gonorrhea
  • Chlamydia
  • Herpes Simplex Virus
  • Human Papillomavirus (HPV)
  • Syphilis
  • Other diseases (HIV, Hepatitis B, Chancroid, and Trichomoniasis)

Market by Location of Testing

  • Laboratory Testing
  • Point of Care (POC) Testing

Table Of Contents:

CHAPTER 1. Industry Overview of STD Testing Market

1.1. Definition and Scope

1.1.1. Definition of STD Testing

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global STD Testing Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. STD Testing Market By Disease Type

1.2.3. STD Testing Market By Location of Testing

1.2.4. STD Testing Market By Region

CHAPTER 2. Research Approach

2.1. Methodology

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of STD Testing Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for STD Testing Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. STD Testing Market By Disease Type

4.1. Introduction

4.2. STD Testing Revenue By Disease Type

4.2.1. STD Testing Revenue (USD Billion) and Forecast, By Disease Type, 2018-2030

4.2.2. Gonorrhea

4.2.2.1. Gonorrhea Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3. Chlamydia

4.2.3.1. Chlamydia Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4. Herpes Simplex Virus

4.2.4.1. Herpes Simplex Virus Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5. Syphilis

4.2.5.1. Syphilis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6. Human Papillomavirus (HPV)

4.2.6.1. Human Papillomavirus (HPV) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.7. Other Diseases (Human Immunodeficiency Virus (HIV), Chancroid, Trichomoniasis, and Hepatitis B)

4.2.7.1. Other Diseases (Human Immunodeficiency Virus (HIV), Chancroid, Trichomoniasis, and Hepatitis B) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 5. STD Testing Market By Location of Testing

5.1. Introduction

5.2. STD Testing Revenue By Location of Testing

5.2.1. STD Testing Revenue (USD Billion) and Forecast, By Location of Testing, 2018-2030

5.2.2. Laboratory Testing

5.2.2.1. Laboratory Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Point of Care (POC) Testing

5.2.3.1. Point of Care (POC) Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. North America STD Testing Market By Country 

6.1. North America STD Testing Market Overview

6.2. U.S.

6.2.1. U.S. STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

6.2.2. U.S. STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

6.3. Canada

6.3.1. Canada STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

6.3.2. Canada STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

6.4. North America PEST Analysis

CHAPTER 7. Europe STD Testing Market By Country

7.1. Europe STD Testing Market Overview

7.2. U.K.

7.2.1. U.K. STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

7.2.2. U.K. STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

7.3. Germany

7.3.1. Germany STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

7.3.2. Germany STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

7.4. France

7.4.1. France STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

7.4.2. France STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

7.5. Spain

7.5.1. Spain STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

7.5.2. Spain STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

7.6. Rest of Europe

7.6.1. Rest of Europe STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

7.6.2. Rest of Europe STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

7.7. Europe PEST Analysis

CHAPTER 8. Asia Pacific STD Testing Market By Country

8.1. Asia Pacific STD Testing Market Overview

8.2. China

8.2.1. China STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

8.2.2. China STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

8.3. Japan

8.3.1. Japan STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

8.3.2. Japan STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

8.4. India

8.4.1. India STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

8.4.2. India STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

8.5. Australia

8.5.1. Australia STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

8.5.2. Australia STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

8.6. South Korea

8.6.1. South Korea STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

8.6.2. South Korea STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

8.7. Rest of Asia-Pacific

8.7.1. Rest of Asia-Pacific STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

8.7.2. Rest of Asia-Pacific STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

8.8. Asia Pacific PEST Analysis

CHAPTER 9. Latin America STD Testing Market By Country

9.1. Latin America STD Testing Market Overview

9.2. Brazil

9.2.1. Brazil STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

9.2.2. Brazil STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

9.3. Mexico

9.3.1. Mexico STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

9.3.2. Mexico STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

9.4. Rest of Latin America

9.4.1. Rest of Latin America STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

9.4.2. Rest of Latin America STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

9.5. Latin America PEST Analysis

CHAPTER 10. Middle East & Africa STD Testing Market By Country 

10.1. Middle East & Africa STD Testing Market Overview

10.2. GCC

10.2.1. GCC STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

10.2.2. GCC STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

10.3. South Africa

10.3.1. South Africa STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

10.3.2. South Africa STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

10.4. Rest of Middle East & Africa

10.4.1. Rest of Middle East & Africa STD Testing Revenue (USD Billion) and Forecast By Disease Type, 2018-2030

10.4.2. Rest of Middle East & Africa STD Testing Revenue (USD Billion) and Forecast By Location of Testing, 2018-2030

10.5. Middle East & Africa PEST Analysis

CHAPTER 11. Player Analysis Of STD Testing Market

11.1. STD Testing Market Company Share Analysis

11.2. Competition Matrix

11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

11.2.2. New Disease Type Launches and Disease Type Enhancements

11.2.3. Mergers And Acquisition In Global STD Testing Market

11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 12. Company Profile

12.1. Abbott Laboratories

12.1.1. Company Snapshot

12.1.2. Business Overview

12.1.3. Financial Overview

12.1.3.1. Revenue (USD Billion), 2021

12.1.3.2. Abbott Laboratories 2021 STD Testing Business Regional Distribution

12.1.4. Disease Type/Service and Specification

12.1.5. Recent Developments & Business Strategy

12.1.6. Manufacturing Plant Footprint Analysis

12.2. Affymetrix

12.3. Alere Inc.

12.4. bioMérieux, Inc.

12.5. Becton Dickinson and Company

12.6. Bio-Rad Laboratories, Inc.

12.7. Cepheid Inc.

12.8. Danaher Corporation

12.9. DiaSorin

12.10. Hologic Inc.

12.11. Orasure

12.12. Roche Holdings AG

Ask Query Here: Richard@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/3052

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

 

admin

Leave a Reply

Your email address will not be published. Required fields are marked *